TABLE 1.
Cancer type | Male/female (n/n) | Max post- diagnosis years | Pin1 expression | ||||||
Survival probability | 5-year survival (%) | ||||||||
Expression | Prognosis | ||||||||
Low | High | Level | status | ||||||
Lower | Higher | expression | expression | cut-off | P score | (Prognosability) | |||
Renal | 591/286 | 16 | Low | High | 64% | 82% | 9.65 | 0.000078 | Yes |
Pancreatic | 96/80 | 7 | Low | High | 7% | 48% | 8.72 | 0.00032 | Yes |
Glioma | 99/54 | 7 | Low | High | 5% (∗) | 12% (∗) | 15.74 | 0.022 | No |
Thyroid | 135/366 | 15 | Low | High | 91% | 100% | 9.19 | 0.031 | No |
Lung | 596/398 | 20 | Low | High | 40% | 47% | 6.16 | 0.029 | No |
Stomach | 229/125 | 10 | Low | High | 26% | 50% | 8.03 | 0.022 | No |
Breast | 12/1063 | 23 | Low | High | 81% | 82% | 7.16 | 0.25 | No |
Cervical | 0/291 | 17 | Low | High | 59% | 74% | 10.81 | 0.0061 | No |
Endometrial | 0/541 | 19 | Low | High | 70% | 80% | 8.61 | 0.044 | No |
Ovarian | 0/373 | 15 | Low | High | 27% | 38% | 13.22 | 0.0072 | No |
Urothelial | 299/107 | 14 | Low | High | 33% | 43% | 7.49 | 0.012 | No |
Head and Neck | 366/133 | 17 | Low | High | 39% | 57% | 8.75 | 0.0065 | No |
Melanoma | 60/42 | 5 | High | Low | 37% (∗) | 0 (∗) | 15.17 | 0.27 | No |
Prostate | 494/0 | 14 | High | Low | 100% | 97% | 11.77 | 0.094 | No |
Testis | 134/0 | 20 | High | Low | 100% | 97% | 8.63 | 0.26 | No |
Liver | 246/119 | 10 | Non-determined | 53% | 46% | 5.4 | 0.190 | No | |
Colorectal | 322/275 | 12 | Non-determined | 63% | 60% | 8.76 | 0.065 | No | |
Total Cases | 3679/4253 | Low:High=3:12 | (∗): 3-year Survival |